CARCINOID TUMOR
Clinical trials for CARCINOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new CARCINOID TUMOR trials appear
Sign up with your email to follow new studies for CARCINOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: CARCINOID TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for slowing advanced neuroendocrine tumors in major trial
Disease control OngoingThis study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …
Matched conditions: CARCINOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New scan aims to spot hidden tumors
Diagnosis OngoingThis study is testing whether a special type of CT scan, called a dual energy CT, can better detect carcinoid tumors in the digestive system. It involves 71 people who already have or are suspected to have these tumors. The goal is to see if this scan can find these tumors more a…
Matched conditions: CARCINOID TUMOR
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC